World Health Organization. Chronic obstructive pulmonary disease (COPD) [Internet]. [cited 2023 Feb 8]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)

2

Soriano JB, Abajobir AA, Abate KH, Abera SF, Agrawal A, Ahmed MB, et al. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the

3 Global Burden of Disease Study 2015. Lancet Respir Med. 2017 Sep 1;5(9):691–706.

David Stav MD, Meir Raz MD. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. IMAJ. 2007;

4. Global Strategy for the Diagnosis Management and Prevention of Chronic Obstructive Pulmonary Disease. 2022.

5

Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG, et al. Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2020 Jun 15;201(12):1508–16.

6 Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, et al. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD. N Engl J Med. 2020 Jul 2;383(1):35–48.

7. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Vol. 187, American Journal of Respiratory and Critical Care Medicine. 2013. p. 347–65.